These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28389881)

  • 1. Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide.
    Foro Arnalot P; Pera O; Rodriguez N; Sanz X; Reig A; Membrive I; Ortiz A; Granados R; Algara M
    Clin Transl Oncol; 2017 Oct; 19(10):1225-1231. PubMed ID: 28389881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of subventricular zone irradiation on outcome of patients with glioblastoma.
    Mathew BS; Kaliyath SB; Krishnan J; Bhasi S
    J Cancer Res Ther; 2018; 14(6):1202-1206. PubMed ID: 30488830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial.
    Elicin O; Inac E; Uzel EK; Karacam S; Uzel OE
    J Neurooncol; 2014 Jun; 118(2):413-419. PubMed ID: 24668610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparative Analysis of the Usefulness of Survival Prediction Models for Patients with Glioblastoma in the Temozolomide Era: The Importance of Methylguanine Methyltransferase Promoter Methylation, Extent of Resection, and Subventricular Zone Location.
    Woo P; Ho J; Lam S; Ma E; Chan D; Wong WK; Mak C; Lee M; Wong ST; Chan KY; Poon WS
    World Neurosurg; 2018 Jul; 115():e375-e385. PubMed ID: 29678708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.
    Chen L; Guerrero-Cazares H; Ye X; Ford E; McNutt T; Kleinberg L; Lim M; Chaichana K; Quinones-Hinojosa A; Redmond K
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):616-22. PubMed ID: 23540348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subventricular zones: new key targets for glioblastoma treatment.
    Khalifa J; Tensaouti F; Lusque A; Plas B; Lotterie JA; Benouaich-Amiel A; Uro-Coste E; Lubrano V; Cohen-Jonathan Moyal E
    Radiat Oncol; 2017 Apr; 12(1):67. PubMed ID: 28424082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
    J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
    J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
    Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
    Lombardi G; Pace A; Pasqualetti F; Rizzato S; Faedi M; Anghileri E; Nicolotto E; Bazzoli E; Bellu L; Villani V; Fabi A; Ferrazza P; Gurrieri L; Dall'Agata M; Eoli M; Della Puppa A; Pambuku A; D'Avella D; Berti F; Rudà R; Zagonel V
    J Neurooncol; 2015 Nov; 125(2):359-67. PubMed ID: 26423801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.
    Weinberg BD; Boreta L; Braunstein S; Cha S
    J Neurooncol; 2018 Jul; 138(3):549-556. PubMed ID: 29546530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.
    Gutenberg A; Bock HC; Reifenberger G; Brück W; Giese A
    Acta Neurochir (Wien); 2013 Mar; 155(3):429-35. PubMed ID: 23254891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
    Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain.
    Graus F; Bruna J; Pardo J; Escudero D; Vilas D; Barceló I; Brell M; Pascual C; Crespo JA; Erro E; García-Romero JC; Estela J; Martino J; García-Castaño A; Mata E; Lema M; Gelabert M; Fuentes R; Pérez P; Manzano A; Aguas J; Belenguer A; Simón A; Henríquez I; Murcia M; Vivanco R; Rojas-Marcos I; Muñoz-Carmona D; Navas I; de Andrés P; Mas G; Gil M; Verger E
    Neuro Oncol; 2013 Jun; 15(6):797-805. PubMed ID: 23460319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.
    Kim YS; Kim SH; Cho J; Kim JW; Chang JH; Kim DS; Lee KS; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):661-7. PubMed ID: 22414280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.
    Beauchesne P; Quillien V; Faure G; Bernier V; Noel G; Quetin P; Gorlia T; Carnin C; Pedeux R
    Int J Cancer; 2016 Mar; 138(6):1538-44. PubMed ID: 26501997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone.
    Adeberg S; König L; Bostel T; Harrabi S; Welzel T; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):886-93. PubMed ID: 25220720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.
    Stupp R; Dietrich PY; Ostermann Kraljevic S; Pica A; Maillard I; Maeder P; Meuli R; Janzer R; Pizzolato G; Miralbell R; Porchet F; Regli L; de Tribolet N; Mirimanoff RO; Leyvraz S
    J Clin Oncol; 2002 Mar; 20(5):1375-82. PubMed ID: 11870182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.